We have shown that cortical neurons challenged with toxic concentrations of ␤-amyloid peptide (␤AP) enter the S phase of the cell cycle before apoptotic death. Searching for a signaling molecule that lies at the border between cell proliferation and apoptotic death, we focused on the disialoganglioside GD3. Exposure of rat cultured cortical neurons to 25 M ␤AP(25-35) induced a substantial increase in the intracellular levels of GD3 after 4 hr, a time that precedes neuronal entry into S phase. GD3 levels decreased but still remained higher than in the control cultures after 16 hr of exposure to ␤AP(25-35). Confocal microscopy analysis showed that the GD3 synthesized in response to ␤AP colocalized with nuclear chromatin. The increase in GD3 was associated with a reduction of sphingomyelin (the main source of the ganglioside precursor ceramide) and with the induction of ␣-2,8-sialyltransferase (GD3 synthase), the enzyme that forms GD3 from the monosialoganglioside GM3. A causal relationship between GD3, cell-cycle activation, and apoptosis was demonstrated by treating the cultures with antisense oligonucleotides directed against GD3 synthase. This treatment, which reduced ␤AP(25-35)-stimulated GD3 formation by ϳ50%, abolished the neuronal entry into the S phase and was protective against ␤AP(25-35)-induced apoptosis.
It is currently believed that neuronal degeneration in Alzheimer's disease (AD) is caused by extracellular ␤-amyloid peptide (␤AP) (for review, see Selkoe, 2001) . Cultured neurons exposed to ␤AP predominantly show an apoptotic phenotype (Forloni et al., 1993; Loo et al., 1993) , although neuronal apoptosis by ␤-amyloid is not the only factor that contributes to the pathophysiology of AD (Behl, 2000; Mattson, 2000; Joseph et al., 2001; Roth, 2001; Small et al., 2001) . Molecular determinants of ␤AP-induced neuronal death have been investigated extensively, but they are still poorly defined. In vivo and in vitro studies have shown that an untimely activation of a cell cycle in terminally differentiated neurons may be a requisite antecedent to neuronal apoptosis in AD (Herrup and Busser, 1995; Vincent et al., 1996; Arendt et al., 1998; Busser et al., 1998; Nagy et al., 1998; Copani et al., 1999; Giovanni et al., 1999 Giovanni et al., , 2000 McShea et al., 1999; Yang et al., 2001) . We have shown that full-length ␤AP (fragment 1-42) and its active fragments ␤AP(1-40) and ␤AP(25-35) promote the activation of a cell cycle in differentiated cultured cortical neurons. In particular, ␤AP-treated cortical neurons express the repertoire of proteins necessary to exit quiescence and eventually enter S phase. These neurons undergo apoptosis before entering the G 2 /M phase (Copani et al., 1999) .
Because ␤AP-induced activation of this "neuronal cycle" seems to be critical for the development of apoptosis, it becomes important to disclose the signaling pathway(s) leading to reactivation of the cell cycle in neurons.
Gangliosides, sialic acid-containing glycosphingolipids, constitute a signaling system involved in the modulation of processes of neuronal proliferation and differentiation. GD3 is highly expressed in the embryonic nervous system, particularly in neuroprogenitor cells. GD3 levels are low in the adult brain Svennerholm et al., 1991; Goldman and Reynolds, 1996; Kawai et al., 1998) , although they increase in the brains of patients with AD (Kalanj et al., 1991) and Creutzfeldt-Jakob disease (Ando et al., 1984) . Interestingly, endogenous GD3 neosynthesis is associated with the appearance of a tumor phenotype in melanocytes (Birkle et al., 2000) , and overexpression of GD3 synthase (the ␣-2,8-sialyltransferase that generates GD3 from GM3) enhances the proliferation rate of both rat C6 glioma (Sottocornola et al., 1998) and PC12 pheochromocytoma cell lines (Fukumoto et al., 2000) . Thus, it appears that GD3 is able to modify the cell proliferation status under physiological and pathological conditions.
In the present study we show that mature rat cortical neurons in culture, which respond to ␤AP by re-entering the cell cycle, show an early increase in the intracellular levels of GD3. GD3 synthesis in ␤AP-treated neurons is required for their entrance into the S phase and contributes to the development of apoptosis.
MATERIALS AND METHODS
P ure neuronal culture. Cultures of pure cortical neurons were obtained from rats at embryonic day 15 as described previously (Copani et al., 1999) . Briefly, dissociated cortical cells were plated in a medium consisting of DM EM / Ham's F12 (1:1) supplemented with the following components: 10 mg /ml bovine serum albumin, 10 g /ml insulin, 100 g /ml transferrin, 100 M putrescine, 20 nM progesterone, 30 nM selenium, 2 mM glutamine, 6 mg /ml glucose, 50 U/ml penicillin, and 50 g /ml streptomycin. Cortical cells were plated at a density of 2 ϫ 10 6 cells/dish on 35 mm Nunc (Roskilde, Denmark) dishes precoated with 0.1 mg /ml poly-D-lysine. C ytosine-␤-D-arabinof uranoside (10 M) was added to the cultures 18 hr after plating to avoid the proliferation of non-neuronal elements and was kept for 3 d before medium replacement. This method yields Ͼ99% pure neuronal cultures, as judged by immunocytochemistry for glial fibrillary acidic protein and neuron-specific microtubuleassociated protein 2 (Copani et al., 1999) . ␤AP has always been applied to mature cultures at 8 d in vitro (DIV).
Handling of ␤-amyloid peptide. ␤AP(25-35) and the reverse peptide ␤AP(35-25) were purchased from Bachem AG (Bubendorf, Switzerland) . Different lots of peptides were used. ␤AP(25-35) and ␤AP(35-25) were solubilized in sterile, doubly distilled water at an initial concentration of 2.5 mM and stored frozen at Ϫ20°C. They were used at a final concentration of 25 M in the presence of the glutamate receptor antagonists M K-801 (10 M) and DNQX (30 M) to prevent the excitotoxicity mediated by endogenous glutamate (Copani et al., 1999) .
Addition of antisense oligonucleotides to the cultures. Cultures were also treated with the following "end-capped" phosphorothioate antisense oligonucleotides directed against the enzyme ␣-2,8-sialyltransferase (GD3 synthase): 5Ј-CAGTACAGCCATGGCCCC TC T-3Ј. A scrambled oligonucleotide was used as a control: 5Ј-CGACC TACC TATGCGC T-ACCG-3Ј. Oligonucleotides (3 M) were applied to the cultures 16 hr before the addition of ␤AP (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) .
Fluorescence-activated cell sorter anal ysis. Fluorescence-activated cell sorter analysis was performed as described previously (Copani et al., 1999) . C ells were harvested by incubation with 0.25% trypsin for 3 min, and the suspension was centrif uged at low speed after addition of 50% fetal calf serum. Each pellet was washed with PBS and finally fixed in 70% ethanol. Before staining with propidium iodide (50 g /ml in the dark for 30 min), suspended cells were treated for 1 hr at 37°C with RNase (100 g /ml). The DNA content and ploidy were assessed using a Coulter Elite flow cytometer (Beckman, Fullerton, CA). The Multicycle AV software program (Phoenix Flow Systems, San Diego, CA) was used to analyze cell-cycle distribution profiles.
Evaluation of sphingomyelin hydrol ysis. Cortical neurons were incubated in the presence of [ 3 H]serine (specific activity, 26 C i mmol Ϫ1 ; Amersham Biosciences, Milan, Italy) for 72 hr before exposure to ␤AP(25-35) for 4 hr. The reaction was stopped by adding methanol: chloroform:HC l (100:100:1, v/ v/ v) and a balanced salt solution containing 10 mM EDTA; the aqueous and lipid phases were separated by centrif ugation. Glycerophospholipids present in the lipid phase were saponified in methanolic KOH (0.1 M for 1 hr at 37°C) before resolution of sphingomyelin by sequential one-dimensional TLC, using chloroform: benzene:ethanol (80:40:75, v/ v/ v) followed by chloroform:methanol:28% ammonia (65:25:5, v/ v/ v) as solvents. Plates were analyzed using a digital autoradiographer (Berthold, Bad Wildbad, Germany).
Assessment of intracellular GD3 levels. Cultures were washed twice with ice-cold PBS, pH 7.4, and cells were scraped from the dishes and homogenized. Gangliosides were extracted according to the method of Svennerholm and Fredman (1980) as described previously (Dotta et al., 1998) and analyzed by high-performance TLC (HP TLC) using analytical precoated Silica gel 60 HP TLC plates (Merck, Darmstadt, Germany). All plates were first activated by heating to 100°C for 30 min. Samples were spotted onto plates with a Hamilton syringe in chloroform:methanol:0.25% KC l (5:4:1, v/ v/ v). Authentic GD3 (provided by Fidia S.p.A., Abano Terme, Italy) was used as standard. GD3 was immunodetected by using the R24 anti-GD3 monoclonal antibody (1:100). The plates were incubated for 1 hr at room temperature with the primary antibody, washed twice with PBS -T ween 20, and then incubated for 45 min at room temperature with a horseradish peroxidase-conjugated rabbit antimouse antibody (1:200; Sigma, St. L ouis, MO). Detection was performed by ECL (Amersham Biosciences). The bands were quantified by scanning densitometric analysis.
Immunofluorescence anal ysis of GD3. Cultures were fixed with 2% paraformaldehyde. After incubation with 3% nonimmunized mouse serum in PBS, the R24 anti-GD3 monoclonal antibody (1:100) was applied at 4°C for 72 hr. C ells were washed three times and FI TC -conjugated anti-mouse Ig (1:200; C appel, IC N Biomedicals, Milan, Italy) was applied for 1 hr at room temperature to visualize the labeled sites. Nuclei were stained with propidium iodide (50 g /ml) in PBS. Fluorescence was detected by a Z eiss (Oberkochen, Germany) L SM510 laser scanner microscope.
Reverse transcriptase-PCR anal ysis of GD3 synthase. Total RNA was extracted from cultures of primary cortical neurons essentially as described previously (Auffray and Rougeon, 1980) , except that cells were washed twice with ice-cold PBS and then scraped in 2 ml of cold 3 M LiC l /6 M urea and the procedure was scaled down appropriately. Finally, total RNA was subjected to DNase I treatment (Boehringer Mannheim, Indianapolis, I N) according to the manufacturer's instructions. T wo micrograms of total RNA were then used for cDNA synthesis, using Superscript II (Invitrogen, San Diego, CA) and an oligo(dT) primer according to the manufacturer's instructions. The reverse transcriptase (RT) product was diluted to 100 l with sterile, distilled water, and 1 l of cDNA was used in each subsequent PCR amplification. Amplification of GD3 synthase cDNA was performed using the following primers: forward (5Ј-CCAGCATAATTCGCCAGAGA-3Ј) and reverse (5Ј-TTGCATGTTCACGGAGAAGG-3Ј). For ␤-actin cDNA amplification, the primers were those described by Roelen et al. (1994) , which span an intron and yield products of different sizes depending on whether cDNA or genomic DNA is used as a template (400 bp for a cDNA-derived product and 600 bp for a genomic DNA-derived amplification). Reaction conditions included an initial denaturation step (94°C for 3 min) followed by 45 cycles of 94°C for 30 sec, 55°C for 30 sec, and 72°C for 30 sec. A final extension step (72°C for 10 min) concluded the reaction. PCR products (one-third of the reaction) were analyzed electrophoretically on 2% agarose gels poured and run in 1ϫ Tris acetate-EDTA.
RESULTS
We have shown previously that ␤AP(1-42) or its active fragments ␤AP(1-40) and ␤AP(25-35) reactivate the cell cycle and induce apoptotic death in pure cultures of cortical neurons (Copani et al., 1999) . Because identical effects were seen with the three peptides, we used ␤AP(25-35) in the present study. ␤AP(25-35) (25 M) was applied to mature cultures (8 -9 DIV) in the presence of a mixture of ionotropic glutamate receptor antagonists (10 M MK-801 plus 10 M DNQX) to avoid any endogenous excitotoxic component (Copani et al., 1999) . As expected, ϳ8 -10% of cultured neurons were found in S phase 16 hr after the addition of ␤AP(25-35), whereas no S phase was seen at earlier times (4 or 8 hr). The number of apoptotic neurons increased progressively after 16 hr, reaching Ͼ50% of the cell population at 20 hr (see also Copani et al., 1999) .
TLC analysis combined with immunodetection showed a large increase in GD3 content 4 hr after the addition of ␤AP(25-35) (i.e., at a time that precedes both neuronal entry into S phase and 
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were calculated by a blinded observer from three random fields per culture dish for a total of four to six culture dishes per condition in two to three independent experiments. Each single dish has been considered as an individual value in the statistical analysis (i.e., n ϭ 4 -6). Values are means Ϯ SEM. *p Ͻ 0.05 (one-way ANOVA plus Fisher's least significant difference) versus controls or reverse ␤AP(35-25). Reverse ␤AP(35-25) was not toxic in these experiments. apoptotic death) (Fig. 1) . GD3 levels decreased, but were still higher than in control cultures, 16 hr after the addition of ␤AP(25-35) (Fig. 1 A,B) .
In Figure 2 A,B,D, double-fluorescence analysis of GD3 ( green) and nuclear chromatin (red) showed few neurons expressing GD3 in control cultures or in cultures exposed to the reverse peptide ␤AP . Nearly all neurons became immunopositive for GD3 in neurons exposed to ␤AP(25-35). Immunoreactivity was mostly detected in cell nuclei ( yellow) after the addition of ␤AP(25-35), although it was also found outside the nuclear region in late degenerating neurons (Fig. 2C,D) .
The early increase in GD3 expression paralleled a reduction of the sphingomyelin content in neurons exposed to ␤AP(25-35) for 4 hr (Fig. 3A) , suggesting that GD3 is synthesized after ␤AP(25-35)-induced sphingomyelin hydrolysis. RT-PCR analysis showed that ␤AP(25-35) induced the expression of GD3 synthase mRNA after 2, 8, and 16 hr (Fig. 3B) .
To examine whether the increase in GD3 levels was causally related to the reactivation of the cell cycle and apoptotic death induced by ␤AP, we treated the cultures with a 3 M concentration of end-capped antisense oligonucleotides directed against GD3 synthase for 16 hr before the addition of ␤AP(25-35). GD3 synthase antisense oligonucleotides substantially reduced the rise of neuronal GD3 content induced by ␤AP(25-35) at 4 hr, whereas a scrambled oligonucleotide had a smaller effect (Fig. 4 A) . Cytofluorometric analysis showed that GD3 synthase antisense oligonucleotides abolished the neuronal re-entry into the S phase of the cell cycle in response to ␤AP(25-35) (Fig. 4 B) and substantially protected against ␤AP(25-35)-induced apoptosis (Fig. 4C) . Scrambled oligonucleotides could also reduce ␤AP(25-35)-induced S phase and apoptosis, but their effect was much smaller and was significantly different from that produced by GD3 synthase antisense oligonucleotides (Fig. 4 B,C) .
Together, these results indicate that ␤AP(25-35)-induced GD3 synthesis is antecedent and causally related to neuronal cell-cycle reactivation and apoptosis.
DISCUSSION
After the induction of apoptosis, GD3 accumulates in nonneuronal cells, where it contributes to the death pathway by a dual mechanism that involves the opening of mitochondrial permeability transition pores and the suppression of the nuclear factor-Bdependent survival pathway (De Maria et al., 1997; Kristal and Brown, 1999; Malisan and Testi, 1999; Scorrano et al., 1999; Rippo et al., 2000; Colell et al., 2001) . In neurons, a number of studies have been performed with exogenously added gangliosides (Favaron et al., 1988; Manev et al., 1990; Saito et al., 1998 Saito et al., , 1999 Ryu et al., 1999) , but the functional role of endogenously generated gangliosides in neurodegenerative processes has never been investigated.
In this study, we show that GD3 accumulates in rat cortical neurons that have been exposed to ␤AP(25-35). We have demonstrated previously that mature neurons must re-enter the cell cycle and cross the G 1 /S transition before undergoing ␤AP-induced apoptosis (Copani et al., 1999) . ␤AP-treated cortical neurons express a battery of proteins that are typically expressed by proliferating cells during G 1 /S phases, such as cyclin D1, phosphoretinoblastoma, cyclin E, and cyclin A. Neurons eventually enter the S phase, as shown by quantitative cytofluorometric analysis, and then die by apoptosis before crossing the border between the S and G 2 phases (Copani et al., 1999) . The use of a dexamethasone-inducible cyclin D1 mRNA antisense, a negative dominant mutant of cyclin-dependent kinase type 2 (CDK2) or chemical CDK inhibitors has shown that the unscheduled cell cycle is causally related to apoptotic death in neurons exposed to ␤AP (Copani et al., 1999 (Copani et al., , 2001 . These in vitro studies have their in vivo counterpart in the AD brain, in which Yang et al. (2001) provided evidence for chromosomal replication in "at-risk" neurons. The present data indicate that GD3 is an essential component of the signaling pathway(s) leading to the reactivation of the cell cycle in ␤AP-treated neurons (Fig. 5) . This evidence is consistent with the regulatory functions of GD3 in cellular proliferation and differentiation processes. PC12 cells overexpressing the GD3 synthase gene showed an enhanced rate of proliferation attributable to a sustained activation of the Ras/mitogenactivated protein-extracellular signal-regulated kinase kinase/ extracellular signal-regulated kinase pathway and failed to differentiate in response to NGF (Fukumoto et al., 2000) . In malignant cells, GD3 induces the suppression of differentiation phenotypes and promotes proliferation (Sottocornola et al., 1998; Birkle et al., 2000) .
In neurons that degenerate in response to ␤AP, neosynthesized GD3 accumulated inside the nuclear region and colocalized with nuclear chromatin. In other cell types, in which apoptosis is not associated with a reactivation of the cell cycle, GD3 is instead consistently found outside the nucleus (Malisan and Testi, 1999) . To date, only gangliosides of the "a" series have been described in the cell nucleus. GM1 is found in the nuclear membrane, where its expression is upregulated during axonogenesis (Wu et al., 1995 (Wu et al., , 2001 Kozireski-Chuback et al., 1999) . Interestingly, GM1 inhibits DNA synthesis and the activity of DNA polymerase ␣ in isolated nuclei of HeLa cells (Ohsawa et al., 1988 ). An attractive hypothesis is that GD3 acts as a functional counterpart of GM1 by increasing cell proliferation via a nuclear mechanism. Accordingly, in neurons exposed to ␤AP, GD3 might provide a nuclear signal for the aberrant DNA replication. The evidence that the antisense-induced decrease in GD3 levels was highly effective in preventing the unscheduled S phase, and the ensuing apoptotic phenotype strengthens the hypothesis of a causal relationship among GD3 formation, cell-cycle activation, and neuronal death. However, we cannot exclude the possibility that GD3 contributes to ␤AP-induced apoptosis through additional mechanisms (Fig.  5) , for example by targeting the mitochondrial pathway of cell death.
Ceramide released from sphingomyelin hydrolysis is a likely source for GD3 synthesis (De Maria et al., 1998) . Sphingomyelin hydrolysis might follow the interaction of ␤AP aggregates with a membrane receptor, the identity of which is unknown. The p75 low-affinity neurotrophin receptor is a possible candidate (Yaar et al., 1997) , because this receptor has been shown to transduce the extracellular signal via the activation of acidic sphingomyelinase (Brann et al., 1999; Bilderback et al., 2001) . The finding of an early induction of GD3 synthase in response to ␤AP is particularly interesting because it provides the first evidence that this enzyme is upregulated in response to a death signal. This suggests a novel strategy against ␤AP-induced neurotoxicity based on the pharmacological regulation of GD3 synthase expression.
